Nuzenio

In Pancreatic Cancer

In Pancreatic Cancer news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 16 publisher sources 100/100 entity strength

Latest news

Stephenson Global Scholar Grants Award $6.7 Million to Accelerate Pancreatic Cancer Breakthroughs - FinancialContentFinancialContent · Mon, 10 Aug 2026 16:17:00 GMTTHE LUSTGARTEN FOUNDATION AND BREAK THROUGH CANCER ANNOUNCE NEW CLINICAL TRIAL EVALUATING KRAS-TARGETED IMMUNOTHERAPY STRATEGY FOR PANCREATIC CANCER - PR NewswirePR Newswire · Mon, 10 Aug 2026 13:50:00 GMTAIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 12:42:53 GMTElicio Study to Test Immunotherapy Before Pancreatic Cancer Surgery - Stock TitanStock Titan · Mon, 10 Aug 2026 12:00:00 GMTNew drug delivers promising survival gains in pancreatic cancer - News-MedicalNews-Medical · Mon, 10 Aug 2026 03:11:00 GMTPatients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ - Chicago TribuneChicago Tribune · Sun, 09 Aug 2026 11:00:17 GMT'We're excited and ready to go': Fast-growing Revolution Medicines preps potential launch of blockbuster pancreatic cancer drug - The Business JournalsThe Business Journals · Fri, 07 Aug 2026 13:29:00 GMTWhat Does the Future Hold for Cancer Vaccines in Pancreatic Cancer? - OncLiveOncLive · Fri, 07 Aug 2026 03:16:30 GMT

Timeline

Mon, 10 Aug 2026 16:17:00 GMTStephenson Global Scholar Grants Award $6.7 Million to Accelerate Pancreatic Cancer Breakthroughs - FinancialContent
Mon, 10 Aug 2026 13:50:00 GMTTHE LUSTGARTEN FOUNDATION AND BREAK THROUGH CANCER ANNOUNCE NEW CLINICAL TRIAL EVALUATING KRAS-TARGETED IMMUNOTHERAPY STRATEGY FOR PANCREATIC CANCER - PR Newswire
Mon, 10 Aug 2026 12:42:53 GMTAIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer - The Manila Times
Mon, 10 Aug 2026 12:00:00 GMTElicio Study to Test Immunotherapy Before Pancreatic Cancer Surgery - Stock Titan
Mon, 10 Aug 2026 03:11:00 GMTNew drug delivers promising survival gains in pancreatic cancer - News-Medical
Sun, 09 Aug 2026 11:00:17 GMTPatients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ - Chicago Tribune

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for In Pancreatic Cancer.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

16 distinct publisher/source names are currently connected to this entity page.